Lifeboat Foundation

A California-based startup called JetZero has a different idea: changing the shape of commercial planes and the material they’re made of. The company unveiled its designs for the midsize commercial and military tanker-transport markets this spring, and has big plans to upend the way air travel looks and feels—as well as how much it costs and how much carbon it emits. Tony Fadell, founder of venture capital firm Build Collective and a JetZero investor and strategic advisor, thinks the company could be the “SpaceX of aviation” due to its potential to disrupt the existing business model.

JetZero’s planes, which are still in the concept/prototype phase, have a blended wing body design. That means the wings merge with the main body of the aircraft, rather than being attached to a hollow tube like the planes we travel in today. Picture the body of a manta ray: wide and flat, it tapers off to a narrower fin at each side, with a head and a tail. A blended wing body aircraft isn’t terribly different, though on JetZero’s models the body isn’t quite as wide.

Besides providing a lot more space, this design is more aerodynamic than tube-and-wing planes. JetZero plans to fly its planes at higher altitudes than today’s norm (40 to 45,000 feet rather than 30 to 35,000), and says its airframe will cut fuel burn and emissions in half. It plans to make its planes out of carbon fiber and kevlar (a strong lightweight fiber used for things like body armor, bulletproof vests, car brakes, boats, and aircraft). The company says its planes’ lighter weight and improved aerodynamics would be able to fly at the same speed and range as existing midbody jetliners, but burn half as much fuel in the process.

New technologies will be able to wrap around legacy bank systems and create a new layer of data attribution, ushering in a modern era for accounting and business finance.

AI-enabled accounting takes a proactive approach to processing financial information. This means reducing the likelihood of errors, ensuring greater consistency across the ledger and allowing continuous data monitoring.

Where once bad or missing transaction information led to messy books and uninformed business decisions, advances in AI can now use context clues to categorize transactions accurately from the outset—getting us to a world where transactions can actually be “self-documenting.” This will make accountants’ and business owners’ lives easier while improving overall operating efficiencies.

Visits with a 24/7, co-payment-free telemedicine program established by Penn Medicine for its employees were 23% less expensive than in-person visits for the same conditions, according to a new analysis published in the American Journal of Managed Care.

Researchers at the Perelman School of Medicine at the University of Pennsylvania found that the per-visit costs for the telemedicine program, called Penn Medicine OnDemand, averaged $380 while in-person encounters in primary care offices, emergency departments, or urgent care clinics during the same timeframe cost $493 to conduct, a $113 difference per patient.

“The conditions most often handled by OnDemand are low acuity—non-urgent or semi-urgent issues like respiratory infections, sinus infections, and allergies—but incredibly common, so any kind of cost reduction can make a huge difference for controlling employee benefit costs,” said the study’s lead researcher, Krisda Chaiyachati, MD, an adjunct assistant professor of Medicine at Penn Medicine, who previously served as medical director of Penn Medicine OnDemand and now is the physician lead for Value-based Care and Innovation at Verily. “This research shows the clear financial benefits when hospitals and health systems offer telemedicine services directly to their own employees.”

Stability AI became a $1 billion company with the help of a viral AI text-to-image generator and — per interviews with more than 30 people — some misleading claims from founder Emad Mostaque.

Emad Mostaque is the modern-day Renaissance man who kicked off the AI gold rush. The Oxford master’s degree holder is an award-winning hedge fund manager, a trusted confidant to the United Nations and the tech founder behind Stable Diffusion — the text-to-image generator that broke the internet last summer and, in his words, pressured OpenAI to launch ChatGPT, the bot that mainstreamed AI.

Guy, a recognized industry thought leader, is the president of SmartSense, IoT solutions for the enterprise.

It’s no secret that healthcare systems exist at the intersection of financial risk and operational risk. Amid the market volatility of our current socioeconomic environment, the pressure is on hospitals, clinics and blood banks to maintain healthy profit margins that enable them to keep pace with rising demand for clinical care and prescription medications. The rate of U.S. spending on prescriptions is increasing at a rapid clip, and considering physician-administered drugs provide hospitals with high gross profits, investing in pharmaceutical services is a logical pathway to profitability.

However, severe pharmaceutical compliance regulations related to safety and efficacy—CDC, VFC, FDA, AABB and BOP—create a myriad of risk management issues for healthcare organizations to juggle. In the U.S., adverse drug effects are one of the most common medical errors. All it takes is one mismanaged medication to put a patient’s health at significant risk. And on a global scale, widespread vaccine hesitancy rooted in public skepticism has served as a critical roadblock to mitigating the spread of severe infectious diseases like Covid-19.

Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy.

AI not quite ready to automate all of these today, 2023, but will of automated most by end of 2029.

(Bloomberg) — While artificial intelligence is seeding upheaval across the workforce, from screenwriters to financial advisors, the technology will disproportionately replace jobs typically held by women, according to human resources analytics firm Revelio Labs. Most Read from BloombergChina Is Drilling a 10,000-Meter-Deep Hole Into the EarthInside the Making of Redfall, Xbox’s Latest MisfireDebt-Limit Deal Passes the House, Easing US Default ConcernsWall Street Banks Are Using AI to Rewire the.

Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy.

Is the Quantum for Bio Program Director, at Wellcome Leap (https://wellcomeleap.org/our-team/elicakyoseva/), a $40M +$10M program focused on identifying, developing, and demonstrating biology and healthcare applications that will benefit from the quantum computers expected to emerge in the next 3–5 years.

Wellcome Leap was established with $300 million in initial funding from the Wellcome Trust, the UK charitable foundation, to accelerate discovery and innovation for the benefit of human health, focusing on build bold, unconventional programs and fund them at scale—specifically programs that target global human health challenges, with the goal of achieving breakthrough scientific and technological solutions.

Continue reading “Dr. Elica Kyoseva, Ph.D. — Quantum for Bio Program Director — Wellcome Leap” »